Japan Pharma Execs Say S. Korea Drug Makers Should Follow Their Model
This article was originally published in PharmAsia News
Executive Summary
South Korea's pharmaceutical industry faces a need to change the way it does business as the government caps drug prices, and Daiichi Sankyo suggests following the Japanese business model.